(ZNTL) - Analyzing Zentalis Pharma's Short Interest
Portfolio Pulse from Benzinga Insights
Zentalis Pharma's (NYSE:ZNTL) short interest has fallen by 5.5%, with 17.51 million shares sold short, representing 49.83% of its float. It would take traders 32.5 days to cover their short positions. The company's short interest is significantly higher than its peers, whose average short interest is 14.68%.
June 21, 2024 | 7:45 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Zentalis Pharma's short interest has decreased by 5.5%, with 17.51 million shares sold short, representing 49.83% of its float. This high short interest compared to peers could indicate potential volatility.
The decrease in short interest suggests a slight shift in market sentiment towards Zentalis Pharma. However, the high percentage of shares sold short compared to peers indicates potential for volatility. Traders should monitor the stock closely.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100